PROCEPT BioRobotics (PRCT) News Today $62.52 +1.63 (+2.67%) As of 11:50 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period 4,169 Shares in PROCEPT BioRobotics Co. (NASDAQ:PRCT) Acquired by Cibc World Markets CorpCibc World Markets Corp acquired a new stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,169 shares of the company's stock, valued at approximatelyMarch 25 at 3:53 AM | marketbeat.comProcept BioRobotics announces WATER III randomized-controlled trial resultsMarch 24 at 9:08 PM | markets.businessinsider.comWilliam Blair Keeps Their Buy Rating on PROCEPT BioRobotics (PRCT)March 24 at 4:07 PM | markets.businessinsider.comWATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser EnucleationMarch 24 at 8:00 AM | globenewswire.comQuantbot Technologies LP Grows Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Quantbot Technologies LP lifted its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 102.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,019 shares of the company's stock after buying an addMarch 24 at 5:17 AM | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $94.29 Average PT from BrokeragesMarch 24 at 3:21 AM | americanbankingnews.comWilliam Blair Investment Management LLC Boosts Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)William Blair Investment Management LLC grew its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 12.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 239,285 shares of the company's stock after acquiriMarch 21, 2025 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) EVP Hisham Shiblaq Sells 247 SharesPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) EVP Hisham Shiblaq sold 247 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $57.06, for a total value of $14,093.82. Following the completion of the transaction, the executive vice president now directly owns 63,133 shares in the company, valued at $3,602,368.98. The trade was a 0.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.March 20, 2025 | marketbeat.comInsider Selling: PROCEPT BioRobotics Co. (NASDAQ:PRCT) CFO Sells 733 Shares of StockPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) CFO Kevin Waters sold 733 shares of the firm's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $57.06, for a total transaction of $41,824.98. Following the transaction, the chief financial officer now owns 107,991 shares of the company's stock, valued at approximately $6,161,966.46. This represents a 0.67 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.March 20, 2025 | marketbeat.comReza Zadno Sells 5,475 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) StockPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) CEO Reza Zadno sold 5,475 shares of PROCEPT BioRobotics stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $57.06, for a total value of $312,403.50. Following the transaction, the chief executive officer now owns 173,070 shares in the company, valued at approximately $9,875,374.20. This represents a 3.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.March 20, 2025 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) EVP Hisham Shiblaq Sells 247 SharesMarch 20, 2025 | insidertrades.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to theMarch 19, 2025 | marketbeat.com4,814 Shares in PROCEPT BioRobotics Co. (NASDAQ:PRCT) Purchased by Counterpoint Mutual Funds LLCCounterpoint Mutual Funds LLC acquired a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 4,814 shares of the cMarch 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Acquires 32,015 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)Connor Clark & Lunn Investment Management Ltd. boosted its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 187.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 49,126 shares of the company's stock afterMarch 17, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 23,869 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)Charles Schwab Investment Management Inc. lifted its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 426,434 shares of the company's stock after purchasing an additional 23,8March 17, 2025 | marketbeat.comPROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, NevadaMarch 14, 2025 | globenewswire.comAssetmark Inc. Acquires New Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Assetmark Inc. bought a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,289 shares of the company's stock, valued at approximately $667,000. Other hedgMarch 13, 2025 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Stock Holdings Lowered by Victory Capital Management Inc.Victory Capital Management Inc. reduced its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 20.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 153,006 shares of the company's stock aftMarch 13, 2025 | marketbeat.comProcept BioRobotics: Strong Growth, But Profitability Seems Far AwayMarch 11, 2025 | seekingalpha.comBank of New York Mellon Corp Increases Holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Bank of New York Mellon Corp increased its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 11.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 247,345 shares of the company's stock after buying an additional 24,974 sharesMarch 11, 2025 | marketbeat.comEssex Investment Management Co. LLC Reduces Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Essex Investment Management Co. LLC lessened its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 36.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 51,725 shares of the company's stock after selling 29,267March 10, 2025 | marketbeat.comLisanti Capital Growth LLC Sells 20,280 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)Lisanti Capital Growth LLC cut its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 33.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,685 shares of the company's stockMarch 8, 2025 | marketbeat.comAigen Investment Management LP Makes New $420,000 Investment in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Aigen Investment Management LP bought a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 5,219 shares of the company's stock, valued at appMarch 8, 2025 | marketbeat.comLos Angeles Capital Management LLC Boosts Position in PROCEPT BioRobotics Co. (NASDAQ:PRCT)Los Angeles Capital Management LLC boosted its holdings in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 183.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 12,980 shares of the company's stock after buying an additional 8,399 shares during tMarch 2, 2025 | marketbeat.comLeerink Partnrs Has Negative Forecast for PRCT Q1 EarningsPROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Investment analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of PROCEPT BioRobotics in a research note issued on Tuesday, February 25th. Leerink Partnrs analyst M. Kratky now anticipates that the compaMarch 1, 2025 | marketbeat.comWilliam Blair Analysts Decrease Earnings Estimates for PRCTPROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Equities research analysts at William Blair dropped their Q1 2025 earnings estimates for PROCEPT BioRobotics in a research report issued on Tuesday, February 25th. William Blair analyst B. Vazquez now anticipates that the company will post earMarch 1, 2025 | marketbeat.com4 Analysts Assess PROCEPT BioRobotics: What You Need To KnowFebruary 28, 2025 | benzinga.comFY2029 Earnings Estimate for PRCT Issued By Leerink PartnrsPROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Equities researchers at Leerink Partnrs issued their FY2029 EPS estimates for shares of PROCEPT BioRobotics in a research report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Kratky expects that the company will post earnings ofFebruary 28, 2025 | marketbeat.comWells Fargo Sticks to Its Buy Rating for PROCEPT BioRobotics (PRCT)February 27, 2025 | markets.businessinsider.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) is Taylor Frigon Capital Management LLC's 2nd Largest PositionTaylor Frigon Capital Management LLC decreased its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 26.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 54,367 shares of the company's stock after selling 19,923 shares during tFebruary 27, 2025 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Holdings Raised by Principal Financial Group Inc.Principal Financial Group Inc. grew its position in PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 137.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 162,713 shares of the company's stock after acquiring an additFebruary 27, 2025 | marketbeat.comPROCEPT BioRobotics (PRCT) Receives a Hold from BTIGFebruary 26, 2025 | markets.businessinsider.comProcept BioRobotics price target lowered to $77 from $95 at JefferiesFebruary 26, 2025 | markets.businessinsider.comPROCEPT BioRobotics (NASDAQ:PRCT) Releases Earnings Results, Misses Estimates By $0.01 EPSPROCEPT BioRobotics (NASDAQ:PRCT - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.35) earnings per share for the quarter, missing analysts' consensus estimates of ($0.34) by ($0.01). PROCEPT BioRobotics had a negative net margin of 50.07% and a negative return on equity of 38.57%.February 26, 2025 | marketbeat.comPROCEPT BioRobotics (NASDAQ:PRCT) Releases Earnings Results, Misses Expectations By $0.01 EPSPROCEPT BioRobotics (NASDAQ:PRCT - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.35) EPS for the quarter, missing analysts' consensus estimates of ($0.34) by ($0.01). PROCEPT BioRobotics had a negative return on equity of 38.57% and a negative net margin of 50.07%.February 26, 2025 | marketbeat.comProcept BioRobotics price target lowered to $95 from $105 at Morgan StanleyFebruary 26, 2025 | markets.businessinsider.comProcept BioRobotics price target lowered to $85 from $99 at TD CowenFebruary 26, 2025 | markets.businessinsider.comPROCEPT BioRobotics (NASDAQ:PRCT) Price Target Cut to $95.00 by Analysts at Morgan StanleyMorgan Stanley cut their price target on PROCEPT BioRobotics from $105.00 to $95.00 and set an "overweight" rating for the company in a research note on Wednesday.February 26, 2025 | marketbeat.comProcept BioRobotics price target lowered to $90 from $105 at TruistFebruary 26, 2025 | markets.businessinsider.comPROCEPT BioRobotics (PRCT) Receives a Buy from Piper SandlerFebruary 26, 2025 | markets.businessinsider.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | msn.comPROCEPT BioRobotics (NASDAQ:PRCT) Earns "Buy" Rating from Truist FinancialTruist Financial restated a "buy" rating and issued a $90.00 price target (down from $105.00) on shares of PROCEPT BioRobotics in a research note on Wednesday.February 26, 2025 | marketbeat.comPROCEPT BioRobotics Corporation (PRCT) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comPROCEPT BioRobotics Corporation 2024 Q4 - Results - Earnings Call PresentationFebruary 25, 2025 | seekingalpha.comPROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 ResultsFebruary 25, 2025 | globenewswire.comPROCEPT BioRobotics (NASDAQ:PRCT) Shares Up 4.6% - Time to Buy?PROCEPT BioRobotics (NASDAQ:PRCT) Shares Up 4.6% - Still a Buy?February 24, 2025 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Purchased by New York State Common Retirement FundNew York State Common Retirement Fund grew its stake in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 30.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 189,154 shares of the company's stock after acquiring an additional 44,324 shares duFebruary 24, 2025 | marketbeat.comPROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Recommendation of "Moderate Buy" by AnalystsPROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buyFebruary 22, 2025 | marketbeat.comHussman Strategic Advisors Inc. Purchases Shares of 16,800 PROCEPT BioRobotics Co. (NASDAQ:PRCT)Hussman Strategic Advisors Inc. purchased a new position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1February 21, 2025 | marketbeat.comLyell Wealth Management LP Sells 7,750 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)Lyell Wealth Management LP reduced its position in shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) by 15.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,930 shares of the company's stock after selFebruary 19, 2025 | marketbeat.com Remove Ads Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address PRCT Media Mentions By Week PRCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRCT News Sentiment▼0.810.63▲Average Medical News Sentiment PRCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRCT Articles This Week▼156▲PRCT Articles Average Week Remove Ads Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SOLV News Today SNN News Today PEN News Today STVN News Today GKOS News Today BLCO News Today INSP News Today NARI News Today IRTC News Today NVST News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRCT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRCT Stock Free PRCT Stock Alerts